Zhang, C., Wu, Z., Li, J. W., Zhao, H., & Wang, G. Q. (2020). The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. International journal of antimicrobial agents, 105954. https://www.sciencedirect.com/science/article/pii/S0924857920301047?casa_token=lmnhvsET3-IAAAAA:pFqw0nTFTC0TcI5f6rzqOU78ZdK4kYVRKdoJBGm4nObjkaOiHooLZHdLSdxnpMwUTXR3fh5vYQ